Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zymeworks revenue
Zymeworks's revenue is $26.6 million.
What is Zymeworks's revenue?
- Zymeworks's revenue growth from 2017 to 2021 is -48.59%.
- Zymeworks has 450 employees, and the revenue per employee ratio is $59,166.
- Zymeworks's peak quarterly revenue was $28.9M in 2018(q4).
- Zymeworks peak revenue was $53.0M in 2018.
- Zymeworks annual revenue for 2020 was 39.0M, 32.21% growth from 2019.
- Zymeworks annual revenue for 2021 was 26.6M, -31.7% growth from 2020.
On this page
Zippi applies for you, and finds you a job.
Zymeworks historical revenue
Zymeworks annual revenue
Zymeworks annual revenue over time
| Fiscal year / year | Zymeworks revenue |
|---|---|
| 2017 | $51.8M |
| 2018 | $53.0M |
| 2019 | $29.5M |
| 2020 | $39.0M |
| 2021 | $26.6M |
How accurately did Zymeworks' revenue projections match actual performance?
Zymeworks annual growth
Zymeworks annual growth rate over time
| Year | Zymeworks growth |
|---|---|
| 2018 | 2%↑ |
| 2019 | -44%↓ |
| 2020 | 32%↑ |
| 2021 | -32%↓ |
Zymeworks quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Zymeworks quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | $28.9M |
| 2019 | $11.9M | $7.9M | $7.9M | $1.9M |
| 2020 | $8.3M | $12.4M | $2.6M | $15.7M |
| 2021 | $642,842 | $1.8M | $4.4M | $19.9M |
| 2022 | $1.9M | $5.4M | - | - |
Zymeworks jobs nearby
Do you work at Zymeworks?
Did Zymeworks meet its revenue projections?
Zymeworks financing
Zymeworks received early financing of $1.3M on 2008-03-03.
| Series | Round size | Date |
|---|---|---|
| Angel | $1.3M | 03/2008 |
| Series Unknown | $3.2M | 06/2009 |
| Series Unknown | $8.1M | 09/2011 |
| Series Unknown | $11M | 09/2012 |
| Series Unknown | $15M | 01/2014 |
| Series Unknown | $24.0M | 01/2015 |
| Series Unknown | $1.8M | 02/2015 |
| Series A | $61.5M | 01/2016 |
| Post Ipo Equity | $97.8M | 06/2018 |
| Post Ipo Equity | $201.3M | 06/2019 |
| Post Ipo Equity | $320.8M | 01/2020 |
Zymeworks investors
| Investors | Security type |
|---|---|
| CTI Capital | Series Unknown |
| CTI Capital | Series Unknown |
| Advanced Biotechnologies Venture Fund | Series Unknown |
| Eli Lilly | Series Unknown |
| Fonds de solidarité FTQ | Series Unknown |
| Advanced Biotechnologies Venture Fund | Series Unknown |
| CTI Life Sciences Fund | Series Unknown |
| Fonds de solidarité FTQ | Series A |
| Celgene Corporation | Series A |
| Lumira Ventures | Series A |
| BDC | Series A |
| Brace Pharma Capital | Series A |
| Eli Lilly | Series A |
| Merlin Nexus | Series A |
| Teralys Capital | Series A |
| Northleaf Capital Partners | Series A |
| Perceptive Advisors | Series A |
| Robert Simon | Series A |
| BDC Venture Capital | Series A |
| CTI Life Sciences Fund | Series A |
| Citigroup Global Markets Canada Inc | Post Ipo Equity |
| Wells Fargo Securities Canada | Post Ipo Equity |
| Raymond James Financial, Inc. | Post Ipo Equity |
| MTS Health Partners | Post Ipo Equity |
| Paradigm Capital | Post Ipo Equity |
Zymeworks competitors
Zymeworks's top competitor, Merck, earned an annual revenue of $64.2B.
Zymeworks's smallest competitor is Spectrum Pharmaceuticals with revenue of $10.1M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Moderna | $81,825 | $3.2B | 2,500 | 83 |
| Emergent BioSolutions | $77,521 | $1.6B | 1,834 | 11 |
| Human Genome Sciences | $70,157 | $131.0M | 1,000 | - |
| Spectrum Pharmaceuticals | $84,494 | $10.1M | 235 | - |
| Gilead Sciences | $99,828 | $28.8B | 11,800 | 692 |
| Merck | $90,328 | $64.2B | 74,000 | 2,290 |
| Cubist Pharmaceuticals | $91,725 | $926.4M | 873 | - |
| Vertex Pharmaceuticals | $95,952 | $11.0B | 3,400 | 120 |
| Quidel | $71,489 | $1.7B | 1,500 | - |
| MacroGenics | $77,691 | $150.0M | 307 | 11 |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Zymeworks highest paying jobs
Zippia gives an in-depth look into the details of Zymeworks, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Zymeworks. The employee data is based on information from people who have self-reported their past or current employments at Zymeworks. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Zymeworks. The data presented on this page does not represent the view of Zymeworks and its employees or that of Zippia.
Zymeworks may also be known as or be related to ZYMEWORKS INC., Zymeworks, Zymeworks Biopharmaceuticals Inc., Zymeworks Inc, Zymeworks Inc. and Zymeworks, Inc.